-
公开(公告)号:US20180036394A1
公开(公告)日:2018-02-08
申请号:US15551256
申请日:2016-02-19
申请人: CSL BEHRING GMBH
摘要: The present invention relates to pharmaceutical formulations comprising the C1 esterase inhibitor (“C1-INH”), exhibiting a higher stability for prolonged storage and a reduced kinematic viscosity for ameliorated use in treating or preventing disorders related to kinin formation.